Detailed TOC of Global Personalized Medicine Market Insights, Forecast to 2029
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Medicine Market Size Growth Rate by Type, 2018 VS 2024 VS 2029
1.2.2 Personalized Medicine Diagnostics
1.2.3 Personalized Medical Care
1.2.4 Personalized Medicine Therapeutics
1.2.5 Personalized Nutrition and Wellness
1.3 Market by Application
1.3.1 Global Personalized Medicine Market Size Growth Rate by Application, 2018 VS 2024 VS 2029
1.3.2 Oncology
1.3.3 Central Nervous System (CNS)
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Other Applications
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Medicine Market Perspective (2018-2029)
2.2 Global Personalized Medicine Growth Trends by Region
2.2.1 Personalized Medicine Market Size by Region: 2018 VS 2024 VS 2029
2.2.2 Personalized Medicine Historic Market Size by Region (2018-2024)
2.2.3 Personalized Medicine Forecasted Market Size by Region (2024-2029)
2.3 Personalized Medicine Market Dynamics
2.3.1 Personalized Medicine Industry Trends
2.3.2 Personalized Medicine Market Drivers
2.3.3 Personalized Medicine Market Challenges
2.3.4 Personalized Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Personalized Medicine by Players
3.1.1 Global Personalized Medicine Revenue by Players (2018-2024)
3.1.2 Global Personalized Medicine Revenue Market Share by Players (2018-2024)
3.2 Global Personalized Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Personalized Medicine, Ranking by Revenue, 2021 VS 2024 VS 2024
3.4 Global Personalized Medicine Market Concentration Ratio
3.4.1 Global Personalized Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicine Revenue in 2024
3.5 Global Key Players of Personalized Medicine Head office and Area Served
3.6 Global Key Players of Personalized Medicine, Product and Application
3.7 Global Key Players of Personalized Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Medicine Breakdown Data by Type
4.1 Global Personalized Medicine Historic Market Size by Type (2018-2024)
4.2 Global Personalized Medicine Forecasted Market Size by Type (2024-2029)
5 Personalized Medicine Breakdown Data by Application
5.1 Global Personalized Medicine Historic Market Size by Application (2018-2024)
5.2 Global Personalized Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Personalized Medicine Market Size (2018-2029)
6.2 North America Personalized Medicine Market Size by Type
6.2.1 North America Personalized Medicine Market Size by Type (2018-2024)
6.2.2 North America Personalized Medicine Market Size by Type (2024-2029)
6.2.3 North America Personalized Medicine Market Share by Type (2018-2029)
6.3 North America Personalized Medicine Market Size by Application
6.3.1 North America Personalized Medicine Market Size by Application (2018-2024)
6.3.2 North America Personalized Medicine Market Size by Application (2024-2029)
6.3.3 North America Personalized Medicine Market Share by Application (2018-2029)
6.4 North America Personalized Medicine Market Size by Country
6.4.1 North America Personalized Medicine Market Size by Country: 2018 VS 2024 VS 2029
6.4.2 North America Personalized Medicine Market Size by Country (2018-2024)
6.4.3 North America Personalized Medicine Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Personalized Medicine Market Size (2018-2029)
7.2 Europe Personalized Medicine Market Size by Type
7.2.1 Europe Personalized Medicine Market Size by Type (2018-2024)
7.2.2 Europe Personalized Medicine Market Size by Type (2024-2029)
7.2.3 Europe Personalized Medicine Market Share by Type (2018-2029)
7.3 Europe Personalized Medicine Market Size by Application
7.3.1 Europe Personalized Medicine Market Size by Application (2018-2024)
7.3.2 Europe Personalized Medicine Market Size by Application (2024-2029)
7.3.3 Europe Personalized Medicine Market Share by Application (2018-2029)
7.4 Europe Personalized Medicine Market Size by Country
7.4.1 Europe Personalized Medicine Market Size by Country: 2018 VS 2024 VS 2029
7.4.2 Europe Personalized Medicine Market Size by Country (2018-2024)
7.4.3 Europe Personalized Medicine Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Personalized Medicine Market Size (2018-2029)
8.2 China Personalized Medicine Market Size by Type
8.2.1 China Personalized Medicine Market Size by Type (2018-2024)
8.2.2 China Personalized Medicine Market Size by Type (2024-2029)
8.2.3 China Personalized Medicine Market Share by Type (2018-2029)
8.3 China Personalized Medicine Market Size by Application
8.3.1 China Personalized Medicine Market Size by Application (2018-2024)
8.3.2 China Personalized Medicine Market Size by Application (2024-2029)
8.3.3 China Personalized Medicine Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Personalized Medicine Market Size (2018-2029)
9.2 Asia Personalized Medicine Market Size by Type
9.2.1 Asia Personalized Medicine Market Size by Type (2018-2024)
9.2.2 Asia Personalized Medicine Market Size by Type (2024-2029)
9.2.3 Asia Personalized Medicine Market Share by Type (2018-2029)
9.3 Asia Personalized Medicine Market Size by Application
9.3.1 Asia Personalized Medicine Market Size by Application (2018-2024)
9.3.2 Asia Personalized Medicine Market Size by Application (2024-2029)
9.3.3 Asia Personalized Medicine Market Share by Application (2018-2029)
9.4 Asia Personalized Medicine Market Size by Region
9.4.1 Asia Personalized Medicine Market Size by Region: 2018 VS 2024 VS 2029
9.4.2 Asia Personalized Medicine Market Size by Region (2018-2024)
9.4.3 Asia Personalized Medicine Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Personalized Medicine Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Personalized Medicine Market Size by Type
10.2.1 Middle East, Africa, and Latin America Personalized Medicine Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Personalized Medicine Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Personalized Medicine Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Personalized Medicine Market Size by Application
10.3.1 Middle East, Africa, and Latin America Personalized Medicine Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Personalized Medicine Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Personalized Medicine Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Personalized Medicine Market Size by Country
10.4.1 Middle East, Africa, and Latin America Personalized Medicine Market Size by Country: 2018 VS 2024 VS 2029
10.4.2 Middle East, Africa, and Latin America Personalized Medicine Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Personalized Medicine Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Personalized Medicine Introduction
11.1.4 Abbott Laboratories Revenue in Personalized Medicine Business (2018-2024)
11.1.5 Abbott Laboratories Recent Developments
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Personalized Medicine Introduction
11.2.4 Agilent Technologies Revenue in Personalized Medicine Business (2018-2024)
11.2.5 Agilent Technologies Recent Developments
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Personalized Medicine Introduction
11.3.4 Amgen Revenue in Personalized Medicine Business (2018-2024)
11.3.5 Amgen Recent Developments
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Details
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Personalized Medicine Introduction
11.4.4 Astellas Pharma Revenue in Personalized Medicine Business (2018-2024)
11.4.5 Astellas Pharma Recent Developments
11.5 Astrazeneca
11.5.1 Astrazeneca Company Details
11.5.2 Astrazeneca Business Overview
11.5.3 Astrazeneca Personalized Medicine Introduction
11.5.4 Astrazeneca Revenue in Personalized Medicine Business (2018-2024)
11.5.5 Astrazeneca Recent Developments
11.6 Bayer AG
11.6.1 Bayer AG Company Details
11.6.2 Bayer AG Business Overview
11.6.3 Bayer AG Personalized Medicine Introduction
11.6.4 Bayer AG Revenue in Personalized Medicine Business (2018-2024)
11.6.5 Bayer AG Recent Developments
11.7 Celgene Corporation
11.7.1 Celgene Corporation Company Details
11.7.2 Celgene Corporation Business Overview
11.7.3 Celgene Corporation Personalized Medicine Introduction
11.7.4 Celgene Corporation Revenue in Personalized Medicine Business (2018-2024)
11.7.5 Celgene Corporation Recent Developments
11.8 Glaxosmithkline Plc
11.8.1 Glaxosmithkline Plc Company Details
11.8.2 Glaxosmithkline Plc Business Overview
11.8.3 Glaxosmithkline Plc Personalized Medicine Introduction
11.8.4 Glaxosmithkline Plc Revenue in Personalized Medicine Business (2018-2024)
11.8.5 Glaxosmithkline Plc Recent Developments
11.9 Illumina
11.9.1 Illumina Company Details
11.9.2 Illumina Business Overview
11.9.3 Illumina Personalized Medicine Introduction
11.9.4 Illumina Revenue in Personalized Medicine Business (2018-2024)
11.9.5 Illumina Recent Developments
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Personalized Medicine Introduction
11.10.4 Johnson & Johnson Revenue in Personalized Medicine Business (2018-2024)
11.10.5 Johnson & Johnson Recent Developments
11.11 Laboratory Corporation
11.11.1 Laboratory Corporation Company Details
11.11.2 Laboratory Corporation Business Overview
11.11.3 Laboratory Corporation Personalized Medicine Introduction
11.11.4 Laboratory Corporation Revenue in Personalized Medicine Business (2018-2024)
11.11.5 Laboratory Corporation Recent Developments
11.12 Merck
11.12.1 Merck Company Details
11.12.2 Merck Business Overview
11.12.3 Merck Personalized Medicine Introduction
11.12.4 Merck Revenue in Personalized Medicine Business (2018-2024)
11.12.5 Merck Recent Developments
11.13 Novartis AG
11.13.1 Novartis AG Company Details
11.13.2 Novartis AG Business Overview
11.13.3 Novartis AG Personalized Medicine Introduction
11.13.4 Novartis AG Revenue in Personalized Medicine Business (2018-2024)
11.13.5 Novartis AG Recent Developments
11.14 Roche Holding AG
11.14.1 Roche Holding AG Company Details
11.14.2 Roche Holding AG Business Overview
11.14.3 Roche Holding AG Personalized Medicine Introduction
11.14.4 Roche Holding AG Revenue in Personalized Medicine Business (2018-2024)
11.14.5 Roche Holding AG Recent Developments
11.15 Siemens AG
11.15.1 Siemens AG Company Details
11.15.2 Siemens AG Business Overview
11.15.3 Siemens AG Personalized Medicine Introduction
11.15.4 Siemens AG Revenue in Personalized Medicine Business (2018-2024)
11.15.5 Siemens AG Recent Developments
11.16 Takeda Pharmaceutical Company Limited
11.16.1 Takeda Pharmaceutical Company Limited Company Details
11.16.2 Takeda Pharmaceutical Company Limited Business Overview
11.16.3 Takeda Pharmaceutical Company Limited Personalized Medicine Introduction
11.16.4 Takeda Pharmaceutical Company Limited Revenue in Personalized Medicine Business (2018-2024)
11.16.5 Takeda Pharmaceutical Company Limited Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
